Intervention Review

Terazosin for benign prostatic hyperplasia

  1. Timothy J Wilt1,*,
  2. R William Howe2,
  3. Indy Rutks3,
  4. Roderick MacDonald1

Editorial Group: Cochrane Urology Group

Published Online: 7 SEP 2011

Assessed as up-to-date: 13 SEP 1999

DOI: 10.1002/14651858.CD003851.pub2

How to Cite

Wilt TJ, Howe RW, Rutks I, MacDonald R. Terazosin for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD003851. DOI: 10.1002/14651858.CD003851.pub2.

Author Information

  1. 1

    VAMC, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

  2. 2

    Lostwithiel Medical Practice, Lostwithiel, Cornwall, UK

  3. 3

    VAMC, Department of Internal Medicine (111-0), Minneapolis, Minnesota, USA

*Timothy J Wilt, General Internal Medicine (111-0), VAMC, One Veterans Drive, Minneapolis, Minnesota, 55417, USA.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 7 SEP 2011


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.